Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 2

NCT05732129

The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination…

Preclinical data support the investigation of PARP inhibitors in other neoplasms exhibiting homologous recombination deficiency (HRD) as monotherapy as well as…

China29 participantsStarted 2023-03-01

Treatment: Fluzoparib, Irinotecan